Digitalization of Payments: Advantages and Challenges. An Exploratory Literature Review
Applied Business: Issues & Solutions · 03.08.2026 · 3 · 43-48
DOI: 10.57005/ab.2026.3.6 ↗Kurz gefasst
Fachartikel in der Zeitschrift Applied Business: Issues & Solutions, online erschienen am 03.08.2026. Verfasst von Adrija Grigė.
Abstract (Originalsprache)
Digitalization of Payments is an ongoing project; financial institutions invest their time and money to automate processes. However, every invention and new technology requires good expertise and testing to ensure that the process still adheres to regulatory requirements. The goal of this exploratory literature review is to investigate the advantages and challenges of innovations such as electronic and mobile payments, and, more broadly, the adoption of digital technologies in the payments sphere. Multiple articles containing the word ‘payments’ were reviewed to identify the main sections on digitalization processes, focusing on those that mainly affect banks, financial institutions, international payments, and consumer behaviours. Government and financial institutions are focusing on and investing in new technologies to reduce cash payments and standardize international payments; however, the challenge of adopting these innovations creates difficulties and raises the question of whether a cashless economy is possible at all.
Zitieren
APA
Grigė, A. (2026). Digitalization of Payments: Advantages and Challenges. An Exploratory Literature Review. Applied Business: Issues & Solutions, 3, 43-48. https://doi.org/10.57005/ab.2026.3.6
Vancouver
Grigė A. Digitalization of Payments: Advantages and Challenges. An Exploratory Literature Review. Applied Business: Issues & Solutions. 2026;3:43-48. doi:10.57005/ab.2026.3.6
BibTeX
@article{Grig2026,
author = {Grigė, Adrija},
title = {Digitalization of Payments: Advantages and Challenges. An Exploratory Literature Review},
journal = {Applied Business: Issues & Solutions},
year = {2026},
volume = {3},
pages = {43--48},
doi = {10.57005/ab.2026.3.6}
}
EUVIMED